Having observed specific and high-level expression of EVADR in the tumors of patients with lung, colon, rectal, stomach and pancreatic adenocarcinoma, we sought to identify any possible clinical relevance of the association of EVADR with these tumor types. Here, LINC01610 is linked to neoplasm.